Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
This week, the U.S. Food and Drug Administration (FDA) added two new treatments to the armamentarium for hematologic oncologists...
Patient enrollment in clinical trials has long been on the minds of oncologists and researchers. In 1990, fewer than...
As we learned recently, Senator John McCain was diagnosed with glioblastoma multiforme, an aggressive form of central nervous system...
Yesterday, the American Association for Cancer Research (AACR) joined the American Cancer Society (ACS), the American Society of Clinical...
As President of the American Association for Cancer Research (AACR), Michael A. Caligiuri, MD, is a strong advocate for...
Receiving a cancer diagnosis often means navigating numbers, such as estimates of the chance of recurrence. But cancer patients...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Three years ago, the American Association for Cancer Research (AACR) launched this blog with a welcome post from Chief...